Ali Rashidi1, Jan Fritz2. 1. Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA. 2. Department of Radiology, NYU Grossman School of Medicine, New York, New York.
Abstract
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 in Wuhan, China. Although coronavirus disease-19 (COVID-19) affects every population group, the sports community and athletes require special consideration of the effects on cardiovascular, musculoskeletal, neurologic, and respiratory systems. A comprehensive understanding of imaging indications, findings, and features of COVID-19 supports appropriate imaging utilization and effective patient management and treatment. PURPOSE: To review the spectrum of sports imaging in COVID-19 infection, organ system manifestations, vaccine effects, and complications in recreational and competitive athletes. STUDY DESIGN: Narrative review. LEVEL OF EVIDENCE: Levels 4 and 5. METHODS: Based on a PubMed database search, studies describing the imaging findings of COVID-19 infection, organ system manifestations, vaccine effects, and complications in recreational and competitive athletes were included. RESULTS: On March 11, 2020, World Health Organization officially declared COVID-19 a global pandemic. As of May 9, 2022, more than 515 million confirmed cases of COVID-19 were reported globally. While the multisystem effects of COVID-19 are incompletely understood, the role of imaging in diagnosing, monitoring, and prognosticating active disease, long-term effects, and complications is evolving. In the respiratory system, imaging plays an important role in diagnosing, characterizing, and monitoring pulmonary COVID-19 infections, barotrauma, and COVID-19-associated chronic pulmonary opacities and fibrotic-like lung changes. Ultrasonography, computed tomography, and magnetic resonance imaging aid in the timely diagnosis of ischemic, embolic, and thrombotic peripheral and central cardiovascular events, including deep venous thrombosis, pulmonary embolism, myocarditis, and stroke. COVID-19-associated musculoskeletal and peripheral nervous system manifestations include rhabdomyolysis and myonecrosis, plexus and peripheral neuropathies, Guillain-Barré syndrome, and shoulder injury related to vaccine administration. CONCLUSION: In athletes, COVID-19 infections and associated effects on cardiovascular, musculoskeletal, neurologic, and respiratory systems require special consideration. With the increasing understanding of the multisystem effects of COVID-19, the role of imaging in diagnosing, monitoring, and prognosticating active disease, long-term effects, and complications is evolving. A comprehensive understanding of imaging indications, COVID-19 imaging features, and organ system effects aids in appropriate imaging utilization and effective patient management and treatments.
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 in Wuhan, China. Although coronavirus disease-19 (COVID-19) affects every population group, the sports community and athletes require special consideration of the effects on cardiovascular, musculoskeletal, neurologic, and respiratory systems. A comprehensive understanding of imaging indications, findings, and features of COVID-19 supports appropriate imaging utilization and effective patient management and treatment. PURPOSE: To review the spectrum of sports imaging in COVID-19 infection, organ system manifestations, vaccine effects, and complications in recreational and competitive athletes. STUDY DESIGN: Narrative review. LEVEL OF EVIDENCE: Levels 4 and 5. METHODS: Based on a PubMed database search, studies describing the imaging findings of COVID-19 infection, organ system manifestations, vaccine effects, and complications in recreational and competitive athletes were included. RESULTS: On March 11, 2020, World Health Organization officially declared COVID-19 a global pandemic. As of May 9, 2022, more than 515 million confirmed cases of COVID-19 were reported globally. While the multisystem effects of COVID-19 are incompletely understood, the role of imaging in diagnosing, monitoring, and prognosticating active disease, long-term effects, and complications is evolving. In the respiratory system, imaging plays an important role in diagnosing, characterizing, and monitoring pulmonary COVID-19 infections, barotrauma, and COVID-19-associated chronic pulmonary opacities and fibrotic-like lung changes. Ultrasonography, computed tomography, and magnetic resonance imaging aid in the timely diagnosis of ischemic, embolic, and thrombotic peripheral and central cardiovascular events, including deep venous thrombosis, pulmonary embolism, myocarditis, and stroke. COVID-19-associated musculoskeletal and peripheral nervous system manifestations include rhabdomyolysis and myonecrosis, plexus and peripheral neuropathies, Guillain-Barré syndrome, and shoulder injury related to vaccine administration. CONCLUSION: In athletes, COVID-19 infections and associated effects on cardiovascular, musculoskeletal, neurologic, and respiratory systems require special consideration. With the increasing understanding of the multisystem effects of COVID-19, the role of imaging in diagnosing, monitoring, and prognosticating active disease, long-term effects, and complications is evolving. A comprehensive understanding of imaging indications, COVID-19 imaging features, and organ system effects aids in appropriate imaging utilization and effective patient management and treatments.
Authors: Mina K Chung; David A Zidar; Michael R Bristow; Scott J Cameron; Timothy Chan; Clifford V Harding; Deborah H Kwon; Tamanna Singh; John C Tilton; Emily J Tsai; Nathan R Tucker; John Barnard; Joseph Loscalzo Journal: Circ Res Date: 2021-04-15 Impact factor: 17.367
Authors: Curt J Daniels; Saurabh Rajpal; Joel T Greenshields; Geoffrey L Rosenthal; Eugene H Chung; Michael Terrin; Jean Jeudy; Scott E Mattson; Ian H Law; James Borchers; Richard Kovacs; Jeffrey Kovan; Sami F Rifat; Jennifer Albrecht; Ana I Bento; Lonnie Albers; David Bernhardt; Carly Day; Suzanne Hecht; Andrew Hipskind; Jeffrey Mjaanes; David Olson; Yvette L Rooks; Emily C Somers; Matthew S Tong; Jeffrey Wisinski; Jason Womack; Carrie Esopenko; Christopher J Kratochvil; Lawrence D Rink Journal: JAMA Cardiol Date: 2021-05-27 Impact factor: 14.676
Authors: Han W Kim; Elizabeth R Jenista; David C Wendell; Clerio F Azevedo; Michael J Campbell; Stephen N Darty; Michele A Parker; Raymond J Kim Journal: JAMA Cardiol Date: 2021-10-01 Impact factor: 30.154
Authors: Nathaniel P Disser; Andrea J De Micheli; Martin M Schonk; Maxwell A Konnaris; Alexander N Piacentini; Daniel L Edon; Brett G Toresdahl; Scott A Rodeo; Ellen K Casey; Christopher L Mendias Journal: J Bone Joint Surg Am Date: 2020-07-15 Impact factor: 6.558
Authors: James McKinney; Kim A Connelly; Paul Dorian; Anne Fournier; Jack M Goodman; Nicholas Grubic; Saul Isserow; Nathaniel Moulson; François Philippon; Andrew Pipe; Paul Poirier; Taryn Taylor; Jane Thornton; Mike Wilkinson; Amer M Johri Journal: Can J Cardiol Date: 2020-11-26 Impact factor: 5.223